China Medical GatewayLoading your healthcare gateway…

Qiu Lu Gui

Qiu Lu Gui — Chief Physician — Lymphoma Center — Chinese Academy of Medical Sciences Hematology Hospital

Specialties

Tumors of the lymphatic system include the diagnosis and treatment of acute and chronic lymphocytic leukemia, malignant lymphoma, and multiple myeloma, hematopoietic stem cell transplantation for the treatment of blood diseases, and the diagnosis and treatment of chronic myeloid leukemia.

Education

Graduated in 1991 from the Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, with a master's degree in medicine.

Professional Experience

Qiu Lugui, male, chief physician, professor, Director of the Lymphoma Diagnosis and Treatment Center, graduated from the Graduate School of the Chinese Academy of Medical Sciences and Peking Union Medical College in 1991 with a master's degree in medicine. From 1996 to 1999, he conducted postdoctoral research at the University of Louisville Cancer Center in the United States. He is currently the Director of the Lymphoma Diagnosis and Treatment Center at the Hematology Hospital and the Principal Investigator of the State Key Laboratory of Experimental Hematology, and concurrently serves as the Medical Director of the Tianjin Cord Blood Hematopoietic Stem Cell Bank. He currently leads four research projects, including the Key Project of the National Natural Science Foundation, the International Cooperation Key Project of the National Natural Science Foundation, and the National Medical Innovation Engineering Project, as well as organizes more than ten phase I–III clinical trials of new drugs. He is recognized as a distinguished young and middle-aged expert in health and family planning, a member of the first batch of Famous Doctors of Tianjin, an outstanding talent of the first level of Tianjin's '131' Talent Program, and a recipient of the May 1st Labor Medal of Tianjin. He has also won the First Prize of the Tianjin Science and Technology Progress Award twice.

Professional Roles

Member of the IMS (International Myeloma Society) Membership Committee, member of the International Myeloma Working Group Expert Committee, editorial board member of Blood Advances; Chairman of the Hematologic Oncology Professional Committee of the Chinese Anti-Cancer Association, Vice Chairman of the China Lymphoma Research Alliance, Deputy Director of the Hematology Branch of the Chinese Medical Education Association, Chairman of the Hematologic Oncology Professional Committee of the Tianjin Anti-Cancer Association, among other positions.

Return to Home